Change of p16INK4a and PNCA protein expression in myocardium after injection of hIGF-1 gene modified skeletal myoblasts into post-infarction rats

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 28, Issue 4, 2008, Pages 396-400

  Gao, Yanzhang ^a   Lu, Yongxin ^a   Mi, Shaohua ^a   Liu, Xiaoming ^a   Su, Guanhua ^a   Rong, Shuling ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Heart failure; Insulin like growth factor 1; Modified myoblasts; P16 INK4a; PCNA

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLINE; SOMATOMEDIN C;

ANIMAL; ARTICLE; GENE THERAPY; GENETICS; HEART INFARCTION; HEART MUSCLE; MALE; METABOLISM; MYOBLAST; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P16; GENETIC THERAPY; INSULIN-LIKE GROWTH FACTOR I; MALE; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; MYOCARDIUM; PROLIFERATING CELL NUCLEAR ANTIGEN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 49749125901     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-008-0406-0     Document Type: Article

References (25)

1. Nadal-Ginard B, Kajstura J, Leri A et al. Myocyte death, growth, and regeneration in cardiac hypertrophy and failure. Circ Res, 2003,92(2):139-150
2. Anversa P, Leri A, Kajstura J. Cardiac Regeneration. J Am Coll Cardiol, 2006,47(9):1769-1776
3. Musaro A, Giacinti C, Borsellino G et al. Stem cell-mediated muscle regeneration is enhanced by local isoformof insulin-like growth factor 1. Proc Natl Acad Sci USA, 2004,101(5):1206-1210
4. Anversa P, Olivetti G. Cellular basis of physiologic and pathologic myocardial growth. In: Page E, Fozzard HA, Solaro R J, editors. Handbook of Physiology; Vol. I: The Cardiovascular System; Section 2: The Heart. New York, NY: Oxford University Press, 2001:75-144
5. Rong S L, Lu Y X, Gao Y Z et al. Effects of recombinant retroviral vector mediated human insulin like growth factor-1 gene transfection on skeletal muscle growth in rat. Chin Med J, 2006,119(23):1991-1998
6. Lu T W, Tian J, Jiang D Q et al. Establishment of acute myocardial infarction model in rats. Chin J Comp Med (Chinese), 2004,14(3):166-169
7. Sundgren N C, Giraud G D, Schultz J M et al. Extracellular signal-regulated kinase and phosphoinositol-3 kinase mediate IGF-1 induced proliferation of fetal sheep cardiomyocytes. Am J Physiol Regul Integr Comp Physiol, 2003,285(6):R1481-R1489
8. Foncea R, Andersson M, Ketterman A et al. Insulin-like growth factor-I rapidly activates multiple signal transduction pathways in cultured rat cardiac myocytes. J Biol Chem, 1997,272(31):19115-19124
9. Sriraman V, Rao V S, Sairam M R et al. Effect of deprival of LH on Leydig cell proliferation: involvement of PCNA, cyclin D3 and IGF-1. Mol Cell Endocrinol, 2000,162(1):113-120
10. Gomez G, Lee H M, He Q et al. Acute pancreatitis signals activation of apoptosis-associated and survival genes in mice. Exp Biol Med (Maywood), 2001,226(7):692-700
11. Cheng W, Reiss K, Kajstura J et al. Down-regulation of the IGF-Isystem parallels the attenuation in the proliferative capacity of rat ventricular myoctes during postnatal development. Lab Invest, 1995,72:646-655
12. Zhang W, Lee J C, Kumar S et al. ERK pathway mediates the activation of Cdk2 in IGF-1-induced proliferation of human osteosarcoma MG-63 cells. J Bone Miner Res, 1999,14(4):528-535
13. Wilker E, Lu J, Rho O et al. Role of PI3K/Akt signaling in insulin-like growth factor-1 (IGF-1) skin tumor promotion. Mol Carcinog, 2005,44(2):137-145
14. Linke A, Muller P, Nurzynska D et al. Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infracted myocardium, improving cardiac function. Proc Natl Acad Sci USA, 2005,102(25):8966-8971
15. Vasan R S, Sullivan L M, Agostino R B et al. Serum insulin-like growth factor 1 and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med, 2003,139(8): 642-648
16. Donath M Y, Sutsch G, Yan X W et al. Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure. J Clin Endocrinol Metab, 1998,83(9):3177-3183
17. Donath M Y, Zapf J. Insulin-like growth factor I: an attractive option for chronic heart failure? Drugs Aging, 1999,15(4):251-254
18. Koundrioukoff S, Jonsson Z O, Hasan S et al. A direct interaction between proliferating cell nuclear antigen (PCNA) and Cdk2 targets PCNA interacting proteins for phosphorylation. J Biol Chem, 2000,275,22882-22887
19. Kelman Z. PCNA: structure, functions and interactions. Oncogene, 1997,14:629-640
20. Scovassi A I, Prosperi E. Analysis of proliferating cell nuclear antigen (PCNA) associated with DNA. Methods Mol Biol, 2006,314:457-475
21. Stein G H, Dullinger L F, Soulard A et al. Different roles for cyclin-dependent kinases inhibitors p16 and p21 in the mechanisms of senescence and differentiation in human fibroblasts. Mol Cell Biol, 1999,19:2109-2117
22. Takahashi A, Ohtani N, Yamakoshi K et al. Mitogenic signalling and the p16INK4a-Rb pathway cooperate to enforce irreversible cellular senescence. Nat Cell Biol, 2006,8(11):1291-1297
23. Dhawan J, Pan L C, Pavlath G K et al. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science, 1991,254:1509-1512
24. Vilquin J T. Myoblast transplantation: clinical trials and perspectives. Acta Myol, 2005,24(2):119-127
25. Anker S D, Volterrani M, Pflaum C D et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone. J Am Coll Cardiol, 2001,38:443-452